{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:30:26Z","timestamp":1773675026952,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,26]]},"DOI":"10.7759\/cureus.70248","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:44:36Z","timestamp":1727354676000},"source":"Crossref","is-referenced-by-count":2,"title":["Gastrointestinal Bleeding After Percutaneous Coronary Intervention: Incidence, Risk Factors, and Outcomes"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Al-Hatmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Al-Habsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Al-Ghafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raiyan","family":"Al-Siyabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinad","family":"Al-Ruheili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K","family":"Nadar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said A","family":"Al-Busafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001039","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Lawton JS","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al.. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e4-e17. 10.1161\/CIR.0000000000001039","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41311","article-title":"Advancements in percutaneous coronary intervention techniques: a comprehensive literature review of mixed studies and practice guidelines","volume":"15","author":"Abubakar M","year":"2023","unstructured":"Abubakar M, Javed I, Rasool HF, et al.. Advancements in percutaneous coronary intervention techniques: a comprehensive literature review of mixed studies and practice guidelines. Cureus. 2023, 15:e41311. 10.7759\/cureus.41311","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"McQuaid KR","year":"2006","unstructured":"McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006, 119:624-38. 10.1016\/j.amjmed.2005.10.039","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2015.10.1.22","article-title":"Major bleeding and adverse outcome following percutaneous coronary intervention","volume":"10","author":"Holroyd EW","year":"2015","unstructured":"Holroyd EW, Mustafa AH, Khoo CW, Butler R, Fraser DG, Nolan J, Mamas MA. Major bleeding and adverse outcome following percutaneous coronary intervention. Interv Cardiol. 2015, 10:22-5. 10.15420\/icr.2015.10.1.22","journal-title":"Interv Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.1323","article-title":"Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention","volume":"66","author":"G\u00e9n\u00e9reux P","year":"2015","unstructured":"G\u00e9n\u00e9reux P, Giustino G, Witzenbichler B, et al.. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol. 2015, 66:1036-45. 10.1016\/j.jacc.2015.06.1323","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0195-668x(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci M","year":"2003","unstructured":"Moscucci M. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003, 24:1815-23. 10.1016\/s0195-668x(03)00485-8","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2024.01.009","article-title":"The prevalence of bleeding after percutaneous coronary interventions: A systematic review and meta-analysis","volume":"76","author":"Heidary Moghadam R","year":"2024","unstructured":"Heidary Moghadam R, Mohammadi A, Salari N, Ahmed A, Shohaimi S, Mohammadi M. The prevalence of bleeding after percutaneous coronary interventions: A systematic review and meta-analysis. Indian Heart J. 2024, 76:16-21. 10.1016\/j.ihj.2024.01.009","journal-title":"Indian Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000321813","article-title":"Gastrointestinal bleeding after percutaneous coronary intervention","volume":"83","author":"Tanigawa T","year":"2011","unstructured":"Tanigawa T, Watanabe T, Nadatani Y, et al.. Gastrointestinal bleeding after percutaneous coronary intervention. Digestion. 2011, 83:153-60. 10.1159\/000321813","journal-title":"Digestion"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14740\/cr322w","article-title":"Incidence of gastrointestinal bleeding after percutaneous coronary intervention: a single center experience","volume":"5","author":"Aziz F","year":"2014","unstructured":"Aziz F. Incidence of gastrointestinal bleeding after percutaneous coronary intervention: a single center experience. Cardiol Res. 2014, 5:8-11. 10.14740\/cr322w","journal-title":"Cardiol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007, 335:806-8. 10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl SR","year":"2002","unstructured":"Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002, 288:2411-20. 10.1001\/jama.288.19.2411","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2021.12.009","article-title":"Incidence, prediction, and outcomes of major bleeding after percutaneous coronary intervention in chinese patients","volume":"2","author":"Ng AK","year":"2022","unstructured":"Ng AK, Ng PY, Ip A, Ling IW, Lam LT, Siu CW. Incidence, prediction, and outcomes of major bleeding after percutaneous coronary intervention in chinese patients. JACC Asia. 2022, 2:341-50. 10.1016\/j.jacasi.2021.12.009","journal-title":"JACC Asia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.031","article-title":"Post-discharge bleeding and mortality following acute coronary syndromes with or without PCI","volume":"76","author":"Marquis-Gravel G","year":"2020","unstructured":"Marquis-Gravel G, Dalgaard F, Jones AD, et al.. Post-discharge bleeding and mortality following acute coronary syndromes with or without PCI. J Am Coll Cardiol. 2020, 76:162-71. 10.1016\/j.jacc.2020.05.031","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1556","article-title":"Association between bleeding events and in-hospital mortality after percutaneous coronary intervention","volume":"309","author":"Chhatriwalla AK","year":"2013","unstructured":"Chhatriwalla AK, Amin AP, Kennedy KF, et al.. Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA. 2013, 309:1022-9. 10.1001\/jama.2013.1556","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2012.11.012","article-title":"Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches","volume":"165","author":"Subherwal S","year":"2013","unstructured":"Subherwal S, Ohman EM, Mahaffey KW, et al.. Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches. Am Heart J. 2013, 165:644-54, 654.e1. 10.1016\/j.ahj.2012.11.012","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli M","year":"2021","unstructured":"Valgimigli M, Frigoli E, Heg D, et al.. Dual antiplatelet therapy after PCI in patients at high bleeding risk. N Engl J Med. 2021, 385:1643-55. 10.1056\/NEJMoa2108749","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29486","article-title":"Radial versus femoral access for coronary interventions: an updated systematic review and meta-analysis of randomized trials","volume":"97","author":"Chiarito M","year":"2021","unstructured":"Chiarito M, Cao D, Nicolas J, et al.. Radial versus femoral access for coronary interventions: an updated systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv. 2021, 97:1387-96. 10.1002\/ccd.29486","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01460.x","article-title":"Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study","volume":"102","author":"Chin MW","year":"2007","unstructured":"Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol. 2007, 102:2411-6. 10.1111\/j.1572-0241.2007.01460.x","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28222","article-title":"In-hospital gastrointestinal bleeding following percutaneous coronary intervention","volume":"95","author":"Kwok CS","year":"2020","unstructured":"Kwok CS, Sirker A, Farmer AD, et al.. In-hospital gastrointestinal bleeding following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020, 95:109-17. 10.1002\/ccd.28222","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021312","article-title":"Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study (STROBE compliant)","volume":"99","author":"Zheng W","year":"2020","unstructured":"Zheng W, Zhang YJ, Liu R, Zhao XD, Ai H. Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study (STROBE compliant). Medicine (Baltimore). 2020, 99:e21312. 10.1097\/MD.0000000000021312","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/00365521003797197","article-title":"Investigation of upper gastrointestinal bleeding after implantation of drug-eluting stents; prospective cohort study","volume":"45","author":"Toyokawa T","year":"2010","unstructured":"Toyokawa T, Inaba T, Ishikawa S, Nakatsu M, Ando M, Tomoda J. Investigation of upper gastrointestinal bleeding after implantation of drug-eluting stents; prospective cohort study. Scand J Gastroenterol. 2010, 45:1097-100. 10.3109\/00365521003797197","journal-title":"Scand J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1517\/14740331003645609","article-title":"Proton pump inhibitors and clopidogrel: is it a significant drug interaction?","volume":"9","author":"Oyetayo OO","year":"2010","unstructured":"Oyetayo OO, Talbert RL. Proton pump inhibitors and clopidogrel: is it a significant drug interaction?. Expert Opin Drug Saf. 2010, 9:593-602. 10.1517\/14740331003645609","journal-title":"Expert Opin Drug Saf"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt DL","year":"2010","unstructured":"Bhatt DL, Cryer BL, Contant CF, et al.. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010, 363:1909-17. 10.1056\/NEJMoa1007964","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2022.05.019","article-title":"Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis","volume":"251","author":"Park DY","year":"2022","unstructured":"Park DY, Wang P, An S, et al.. Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis. Am Heart J. 2022, 251:101-14. 10.1016\/j.ahj.2022.05.019","journal-title":"Am Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.11.028","article-title":"Short duration of DAPT versus de-escalation after percutaneous coronary intervention for acute\u00a0coronary\u00a0syndromes","volume":"15","author":"Laudani C","year":"2022","unstructured":"Laudani C, Greco A, Occhipinti G, et al.. Short duration of DAPT versus de-escalation after percutaneous coronary intervention for acute\u00a0coronary\u00a0syndromes. JACC Cardiovasc Interv. 2022, 15:268-77. 10.1016\/j.jcin.2021.11.028","journal-title":"JACC Cardiovasc Interv"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996, 348:1329-39. 10.1016\/S0140-6736(96)09457-3","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30315-9","article-title":"Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis","volume":"395","author":"Chiarito M","year":"2020","unstructured":"Chiarito M, Sanz-S\u00e1nchez J, Cannata F, et al.. Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. Lancet. 2020, 395:1487-95. 10.1016\/s0140-6736(20)30315-9","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.10.028","article-title":"Magnetically controlled capsule endoscopy for assessment of antiplatelet therapy-induced gastrointestinal injury","volume":"79","author":"Han Y","year":"2022","unstructured":"Han Y, Liao Z, Li Y, et al.. Magnetically controlled capsule endoscopy for assessment of antiplatelet therapy-induced gastrointestinal injury. J Am Coll Cardiol. 2022, 79:116-28. 10.1016\/j.jacc.2021.10.028","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/life13071580","article-title":"Dual antiplatelet therapy: a concise review for clinicians","volume":"13","author":"Virk HU","year":"2023","unstructured":"Virk HU, Escobar J, Rodriguez M, et al.. Dual antiplatelet therapy: a concise review for clinicians. Life (Basel). 2023, 13:10.3390\/life13071580","journal-title":"Life (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban P","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, et al.. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J. 2019, 40:2632-53. 10.1093\/eurheartj\/ehz372","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294766-gastrointestinal-bleeding-after-percutaneous-coronary-intervention-incidence-risk-factors-and-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T12:44:38Z","timestamp":1727354678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294766-gastrointestinal-bleeding-after-percutaneous-coronary-intervention-incidence-risk-factors-and-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.70248","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}